This is an application for continued support for years 36-40 of a postdoctoral training program in genetics based in the Department of Molecular and Human Genetics (DMHG). The DMHG is a bridging department with major clinical activities and strong programs in basic science research, but the emphasis of this postdoctoral program is on medical and human genetics and on molecular approaches. There are 79 training faculty, 58 with primary and 21 with secondary appointments in the DMHG. Dr. Beaudet, the current Chair of the DMHG, has served as Program Director for many years and as part of a planned leadership transition of this program, Dr. Lee will be the Program Director starting in 2012. Major research areas in the Program include identifying human disease genes, molecular diagnostics including whole exome analysis, molecular cytogenetics including array CGH, biochemical studies of inborn errors of metabolism, genomic imprinting, molecular dysmorphology, cell and gene therapy, developmental biology and gene targeting in the mouse, genetic control of morphogenesis and development in Drosophila, control of cell cycle, genomic instability, bacterial recombination, genomic sequencing, and genetics of neurological disorders. Trainees include MD or MD/PhD candidates seeking combined clinical and research training or seeking strictly research training, trainees of various degrees seeking combined laboratory diagnostic and research training, and PhD trainees seeking primarily research training in human or nonhuman genetics. The MD trainees generally have completed primary training in pediatrics, medicine, or clinical genetics and PhD trainees most often come directly from completion of graduate school. A major focus of the program is to attract highly qualified MD and MD/PhD trainees who seek clinical training but are also seeking an intensive and substantial research experience. Major strengths of the training environment include a large clinical genetics component;large and sophisticated diagnostic laboratories in cytogenetics, biochemical genetics, and molecular genetics;130,000 square feet of space for the department's various research, clinical, and administrative activities;strong institutional commitment;a genetic graduate student program with relevant course work;an American Board of Medical Genetics (ABMG) certified training program;a high national ranking for research funding;a large program in human genomic sequencing;an NIH funded Intellectual and Developmental Disability Research Center;an NIH funded Mendelian Disease Sequencing Center, and overall depth in molecular genetics.

Public Health Relevance

This is a competing renewal of a longstanding and productive training grant that supports the postdoctoral research of physician scientists and scientists in th area of medical genetics. The program is in its 36th year and has trained leaders both nationally and internationally in medical genetics. The focus has been the training especially of physician scientists in the board certified medical genetics specialties though secondary emphasis has been placed on PhD scientists pursuing research and training in laboratory diagnostic specialties of medical genetics The program is built on a unique integrated model of diverse human genetic, clinical, and model organism training faculty, a robust clinical training program, a large medical genetics diagnostic laboratory medicine program, and specialized research centers such as the human genome sequencing center all integrated within on Department of Molecular and Human Genetics at the Baylor College of Medicine.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Special Emphasis Panel (ZGM1-BRT-5 (PD))
Program Officer
Haynes, Susan R
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Baylor College of Medicine
Schools of Medicine
United States
Zip Code
Farlow, Janice L; Robak, Laurie A; Hetrick, Kurt et al. (2016) Whole-Exome Sequencing in Familial Parkinson Disease. JAMA Neurol 73:68-75
Bostwick, Bret; Fang, Ping; Patel, Ankita et al. (2016) Phenotypic and molecular characterization of focal dermal hypoplasia in 18 individuals. Am J Med Genet C Semin Med Genet 172C:9-20
Gu, Shen; Posey, Jennifer E; Yuan, Bo et al. (2016) Mechanisms for the Generation of Two Quadruplications Associated with Split-Hand Malformation. Hum Mutat 37:160-4
Harel, Tamar; Yesil, Gozde; Bayram, Yavuz et al. (2016) Monoallelic and Biallelic Variants in EMC1 Identified in Individuals with Global Developmental Delay, Hypotonia, Scoliosis, and Cerebellar Atrophy. Am J Hum Genet 98:562-70
Boone, Philip M; Yuan, Bo; Gu, Shen et al. (2016) Hutterite-type cataract maps to chromosome 6p21.32-p21.31, cosegregates with a homozygous mutation in LEMD2, and is associated with sudden cardiac death. Mol Genet Genomic Med 4:77-94
Vetrini, Francesco; D'Alessandro, Lisa C A; Akdemir, Zeynep C et al. (2016) Bi-allelic Mutations in PKD1L1 Are Associated with Laterality Defects in Humans. Am J Hum Genet 99:886-893
Posey, Jennifer E; Rosenfeld, Jill A; James, Regis A et al. (2016) Molecular diagnostic experience of whole-exome sequencing in adult patients. Genet Med 18:678-85
White, Janson; Beck, Christine R; Harel, Tamar et al. (2016) POGZ truncating alleles cause syndromic intellectual disability. Genome Med 8:3
Miller, Marcus J; Bostwick, Bret L; Kennedy, Adam D et al. (2016) Chronic Oral L-Carnitine Supplementation Drives Marked Plasma TMAO Elevations in Patients with Organic Acidemias Despite Dietary Meat Restrictions. JIMD Rep 30:39-44
Burrage, Lindsay C; Miller, Marcus J; Wong, Lee-Jun et al. (2016) Elevations of C14:1 and C14:2 Plasma Acylcarnitines in Fasted Children: A Diagnostic Dilemma. J Pediatr 169:208-13.e2

Showing the most recent 10 out of 101 publications